Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: A population-based study

Archives of Internal Medicine

Volumn 170, Issue 7, 2010, Pages 617-621

  Fischer, Hadas D ^a,b   Juurlink, David N ^a,b   Mamdani, Muhammad M ^a,b,c,d   Kopp, Alexander ^a,b   Laupacis, Andreas ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; NORFLOXACIN; URINARY TRACT ANTIINFECTIVE AGENT; WARFARIN;

AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; UPPER GASTROINTESTINAL BLEEDING; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; AMOXICILLIN; AMPICILLIN; ANTI-INFECTIVE AGENTS, URINARY; ANTICOAGULANTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; ONTARIO; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; WARFARIN;

EID: 77950971972     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.37     Document Type: Article

References (24)

1. Trager WF. Oral anticoagulants. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, eds. Metabolic Drug Interactions. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6)(suppl):160S-198S.
3. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414-1419. (Pubitemid 47052441)
4. Klein TE, Altman RB, Eriksson N, et al; International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med. 2009;360(8):753-764.
5. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095-1106. (Pubitemid 40720733)
6. Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ. 2007;177(4):369-371. (Pubitemid 47339534)
7. Jacobs LG. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Clin Geriatr Med. 2006;22(1):17-32, vii-viii.
8. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol. 2005;45(2):127-132.
9. Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections: the Pittsburgh Good Health Study. Am J Epidemiol. 1995;141(2):145-157.
10. 2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994;89(6):915-923.
11. Juurlink D. Cytochrome P450 Drug Interactions: Compendium of Pharmaceuticals and Specialties. Ottawa, ON: Canadian Pharmacist Association; 2008:L60-L66.
12. Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005;20(7):653-656.
13. Schelleman H, Bilker WB, Brensinger CM, Han X, Kimmel SE, Hennessy S. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther. 2008;84(5):581-588.
14. Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med. 2005;165(2):189-192.
15. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652-1658. (Pubitemid 37430270)
16. Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM. Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol. 2005;25(6):561-564.
17. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52(5):794-798. (Pubitemid 38596502)
18. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):713-718.
19. Raiford DS, Pérez Gutthann S, García Rodríguez LA. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan Hospital automated database. Epidemiology. 1996;7(1):101-104.
20. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984;40(1):63-75.
21. Langholz B. Case-control study, nested. In: Armitage P, Colton C, eds. Encyclopedia of Biostatistics. Chichester, England: John Wiley & Sons Ltd; 1998:514-519.
22. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):e219. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1125071/?tool=pubmed. Accessed January 18, 2010.
23. Penning-van Beest F, Erkens J, Petersen KU, Koelz HR, Herings R. Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur J Clin Pharmacol. 2005;61(5-6):439-444. (Pubitemid 41569322)
24. Penning-van Beest FJ, Koerselman J, Herings RM. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost. 2008;6(2):284-290.